These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23098141)

  • 1. The potential use of the pregnane X receptor in cardiovascular therapy.
    Swales KE; Bishop-Bailey D
    Expert Rev Cardiovasc Ther; 2012 Sep; 10(9):1079-82. PubMed ID: 23098141
    [No Abstract]   [Full Text] [Related]  

  • 2. MicroRNAs and vascular (dys)function.
    Hartmann D; Thum T
    Vascul Pharmacol; 2011 Oct; 55(4):92-105. PubMed ID: 21802526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adipose-Vascular Coupling and Potential Therapeutics.
    Gollasch M
    Annu Rev Pharmacol Toxicol; 2017 Jan; 57():417-436. PubMed ID: 27732801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasoproliferation and antiproliferative treatment options in pulmonary arterial hypertension.
    Blaukovitsch M; Zabel P; Hauber HP
    Recent Pat Cardiovasc Drug Discov; 2009 Jun; 4(2):142-9. PubMed ID: 19519556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular effects of HMG CoA-reductase inhibitors (statins) unrelated to cholesterol lowering: new concepts for cardiovascular disease.
    Lefer AM; Scalia R; Lefer DJ
    Cardiovasc Res; 2001 Feb; 49(2):281-7. PubMed ID: 11164838
    [No Abstract]   [Full Text] [Related]  

  • 6. [Can endothelium be treated with drugs?].
    Fyhrquist F
    Duodecim; 1993; 109(20):1841-7. PubMed ID: 7737007
    [No Abstract]   [Full Text] [Related]  

  • 7. Glycosaminoglycans, proteoglycans and sulodexide and the endothelium: biological roles and pharmacological effects.
    Masola V; Zaza G; Onisto M; Lupo A; Gambaro G
    Int Angiol; 2014 Jun; 33(3):243-54. PubMed ID: 24936533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmunity and autoinflammation: cardiovascular drug targets and design.
    Gasparyan AY
    Curr Pharm Des; 2014; 20(4):483-5. PubMed ID: 23565640
    [No Abstract]   [Full Text] [Related]  

  • 9. Vasoprotective Actions of Nitroxyl (HNO): A Story of Sibling Rivalry.
    Kemp-Harper B
    J Cardiovasc Pharmacol; 2021 Dec; 78(Suppl 6):S13-S18. PubMed ID: 34840263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender and the endothelium.
    Kublickiene K; Luksha L
    Pharmacol Rep; 2008; 60(1):49-60. PubMed ID: 18276985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptor modulation in cardiovascular disease: a target for intervention?
    Földes G; von Haehling S; Anker SD
    Expert Opin Investig Drugs; 2006 Aug; 15(8):857-71. PubMed ID: 16859390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there a therapeutic role for Agmatine?
    Euler DE
    Anadolu Kardiyol Derg; 2006 Mar; 6(1):39-40. PubMed ID: 16524799
    [No Abstract]   [Full Text] [Related]  

  • 13. Endothelial Cells: From Dysfunction Mechanism to Pharmacological Effect in Cardiovascular Disease.
    Haybar H; Shahrabi S; Rezaeeyan H; Shirzad R; Saki N
    Cardiovasc Toxicol; 2019 Feb; 19(1):13-22. PubMed ID: 30506414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted therapies and outcomes data: the inflammatory hypothesis matures.
    Sharan L; Krasuski RA
    Curr Opin Lipidol; 2018 Feb; 29(1):56-57. PubMed ID: 29298276
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiovascular steroid actions: swift swallows or sluggish snails?
    Christ M; Wehling M
    Cardiovasc Res; 1998 Oct; 40(1):34-44. PubMed ID: 9876315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of P-glycoprotein by antiretroviral drugs in human brain microvessel endothelial cells.
    Chan GN; Patel R; Cummins CL; Bendayan R
    Antimicrob Agents Chemother; 2013 Sep; 57(9):4481-8. PubMed ID: 23836171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnane X receptor regulates drug metabolism and transport in the vasculature and protects from oxidative stress.
    Swales KE; Moore R; Truss NJ; Tucker A; Warner TD; Negishi M; Bishop-Bailey D
    Cardiovasc Res; 2012 Mar; 93(4):674-81. PubMed ID: 22166712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting NLRP3 (Nucleotide-Binding Domain, Leucine-Rich-Containing Family, Pyrin Domain-Containing-3) Inflammasome in Cardiovascular Disorders.
    Wang Z; Hu W; Lu C; Ma Z; Jiang S; Gu C; Acuña-Castroviejo D; Yang Y
    Arterioscler Thromb Vasc Biol; 2018 Dec; 38(12):2765-2779. PubMed ID: 30571177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The thromboxane/endoperoxide receptor (TP): the common villain.
    Félétou M; Vanhoutte PM; Verbeuren TJ
    J Cardiovasc Pharmacol; 2010 Apr; 55(4):317-32. PubMed ID: 20422736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caveolae and caveolin-1: novel potential targets for the treatment of cardiovascular disease.
    Frank PG; Hassan GS; Rodriguez-Feo JA; Lisanti MP
    Curr Pharm Des; 2007; 13(17):1761-9. PubMed ID: 17584106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.